Trimethyl(trifluoromethyl)silane, Ruppert’s reagent (TMTFMS)
T.E. Fiodorova
TMTFMS is a colorless volatile liquid with b.p.52-54oC at 10 torr (1),
according to other sources of information b.p.= 54-55oC(2), 53oC
(3), 45oC (4), it is stable for some weeks (5).
Introduction of fluorine into organic molecules as a measure to modify their chemical
and biological properties is a known method used especially wide in pharmachemistry,
agrochemistry and polymer chemistry. A possibility to introduce a fluorine-containing
group as a single whole to a desired position is a particularly attractive way. TMTFMS is
one of reagents providing introduction of the trifluoromethyl group.
TMTFMS became known in 1984 by Ruppert’s report (4) and caused interest as a reagent
for nucleophilic trifluoromethylation under mild conditions of a number of compounds
having an electrophilic functional group, a carbonyl one in particular.
A preparative method described by Ruppert to produce TMTFMS with use of expensive toxic
compounds confined investigations with the use of that reagent. But already from the late
80-s prospecting work on development of process engineering began (6,1,3,7,8,9,10,11) and
already in the middle 90-s a number of publications devoted to the synthesis of TMTFMS and
investigations of reactions with its use dramatically increased. Approximately at that
time the reagent was put up for sale, anyway the authors of publications (12,13,14) used
in their work commercial TMTFMS including that supplied by Apollo Scientific Ltd.(14).
Methods to produce TMTFMS, its reactions with compounds of different classes examined in
detail and analyzed in review (2). However in connection with a great number of
publications it is of interest to trace the development of investigations in this area
even for a small period of time (since 1997 till the first half of 1999).
Nucleophilic trifluoromethylation with the use of TMTFMS is carried out in a solvent
and is induced by fluoride ions. The choice of the compound, a donor of the fluoride ion
and a reaction environment, has a determinant significance in every particular synthesis.
Thus, search for a system for carrying out nucleophilic aromatic substitution has shown
that nitro and cyano groups may be replaced with the CF3- groups though in low yields when
a system of TMTFMS/KF/dimethylacetamide is used (14). A melt CsF-CsOH-CsCl (1:1:1),
CsF-CsCl-(1:1), CsF-CsOH-(10:1 –1.3:1 and 1:1) was suggested as a source of fluoride
ion. The interaction of TMTFMS with paramethoxyphenylketone in the presence of CsF-CsOH
(1:1) at 0oC gave a trifluoromethylated derivative in 86% yield (15).
A number of publications contain information about pharmaceutical chemicals including
compounds synthesized with the use of TMTFMS as follows:
- Polycyclic compounds of the net structure in antineoplastic remedies and makeup
prepartions (16)
- Derivatives of oxazolidine-2-one in medications for removal of depressions and phobias,
for medical treatment of Parkinson’s and Alzheimer’s diseases (17).
- Derivatives of piridine-2(1H)-one as an inhibitor of acetylcholinesterase for medical
treatment of Alzheimer’s disease (18)
- CF3-containing artemisin of high antimalarial activity (19)
- Polymethylvinylketene with the CF3- groups as an adsorbent undestroying human
albumin (20)
- Heterocyclic substituted acylanilides in preparations with mixed androgenous and
gestagenous activity (21)
- Derivatives of benzoxizine-2-ones as inhibitors of transcriptase (22).
At that time a research on bioactivity of trifluoromehylated compounds was carried and
syntheses leading to the goal products by direct trifluoromethylation were developed:
- there was studied influence of arrangements of the CF3 group at C-3, C-4, C-5
positions on anticonvulsive/convulsive activity of
 -butyrolactones and -thiobutyrolactones (23)
 -hydroxy--trifluoromethylamides possessing structural analogy
with some antiandrogens having anticancerogenic activity were produced by direct
trifluoromethylation of -ketoamides
in the presence of tetrabutylammonium fluoride in tetrahydrofurane environment at room
temperature. The process proceeds without formation of by-products in 91-96% yield (24). - Trifluoromethylsilane ethers , the raw materials for making
trifluoromethylamides, were produced from the starting ketones and TMTFMS (25)
For the period under review, new methods to produce a number of compounds including
unknown earlier have been developed.
1. With the purpose to produce difluoroenoxysilanes used in synthesis of
hem-difluorocompounds, a method including condensation of TMTFMS with unfluorinated
acylsilane in a medium of methylene chloride at activation with fluoride-ion (
tetrabutylammonium difluorotriphenylstannate as the donor of fluoride-ion) was developed.
Subsequent interaction with enole in the same reactor results in the formation of
difluoro-1,5-diketones. Series of 2,2-difluoro-1,5-diketones were produced , for example
2,2-difluoro-1,5-phenylhexane-1,5-dione. So, in that reaction TMTFMS is the source of
difluoromethylene groups (26).
2. Ketoesters interact with TMTFMS in tetrahydrofurane in the presence of (C4H9)4NF*3H2O
with formation of -alkoxy--trifluoromethylarylacetic acid and its
esters. Methyl--methoxy--trifluoromethylphenylacetate was
produced in 90% yield (27).
3. To obtain trifluoromethylamines and their derivatives being blocks for making
new structures, a method of TMTFMS addition to the C=N bond of nitrons is under
development:
4. Different trifluoromethylketones (TFMK) were synthesized:
- by conversion of methyl ethers including those in enole form (29)
- peptide and nonpeptide TFMK were obtained by conversion of -N-substituted aminoacids to oxazolidine-5-ones with
their subsequent treatment with TMTFMS (5,30) The process was carried out in
tetrahydrofurane in argon atmosphere with initiation with CsF (5). Peptide
trifluoromethylketones being inhibitors of proteolytic enzymes-proteases (pepsin,
trypsin, carboxypeptidase etc) were used in detergent compositions (31,32,33).
5. Active investigations of synthesis of important bioactive compounds with
high-lipophilic CF3S-substituent led to the development of a method of direct
addition of the CF3 group to sulfur (selenium) in sulfur-containing
(selenium-containing) compounds of the general formula RYCN, where Y=S, Se; R=C6H5,
N=n-C8H17, etc. The reaction was carried out in tetrahydrofurane in
the presence of 0.2 equiv of tetrabutylammonium fluoride at 0oC, then at room
temperature. The yield was 70-87% depending on Y and R (13).
6. By interaction of Bi(CF3)3, TMTFMS and tetramethylammonium
fluoride, a new effective reagent of trifluoromethylation,
tetrakis(trifluoromethyl)bismuthate was produced which was a solid substance, stable in
dry nitrogen at room temperature for some days (34).
7. TMTFMS is used in reactions of asymmetric trifluoromethylation conducting in the
presence of chiral Lewis base (35,36), a high enantiomer excess was provided with a large
quantity of TMTFMS. High stereoselectivity was observed in trifluoromethylation of
aminoketones with a side chain, in this case there was no need in promoters
(37).Acylfluorides of N-tritylaminoacids reacting with TMTFMS and NaBH4 form an
intermediate product which allows to obtain enantiomer-pure tritylamino alcohols,
alkenes, trifluoromethylketones (38). The synthesis of trifluoroalkylcarbohydrates was
carried out in anhydrous dichloromethane in the presence of
tetrabutylammoniumdifluorotriphenylstannate. Complete stereoselectivity was observed for
derivatives of 3-oxo-glucose (39).
A reaction of tetramethylammonium fluoride with TMTFMS was investigated (40). TMTFMS is
used in technique both as an independent compound and for production of compounds incoming
into different compositions:
- TMTFMS is used as a process gas for plasma-enriched deposition to produce moisture-proof
dielectric fluorocarbon-containing film based on silicon (41,42,43)
- Optically derivatives of alkylcyclohexane (44,45,46) produced with TMTFMS are used in
compositions of liquid crystals for displays.
As regards publications about methods to produce TMTFMS, two publications (10,11)
relate to electrochemical reduction of fluorohalocarbons in the presence of
trimethylsilane reviewed in detail in (2).
Conclusions
Investigations of different level of development are now under way including production
of new compounds (13,26,27,28,34), optimization of synthesis conditions of known compounds
(14,15,24,25), creation of compositions including compounds produced with TMTFMS for
technical (31,32,33,41,45,46) and medicine (16,17,18,19,20,21,22) purposes, for the latter
trifluoro-containing ketones are of a particular interest because they are able to inhibit
proteases. The mentioned investigations are carried out in many countries including the
USA, Germany, Russia, Japan and other countries.
References
|